KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Dynavax Technologies (DVAX) over the last 15 years, with Sep 2025 value amounting to -$10.0 million.

  • Dynavax Technologies' Change in Accured Expenses fell 377.80% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501,000, marking a year-over-year decrease of 95.97%. This contributed to the annual value of $11.0 million for FY2024, which is 44.30% down from last year.
  • Dynavax Technologies' Change in Accured Expenses amounted to -$10.0 million in Q3 2025, which was down 192.59% from $10.8 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Change in Accured Expenses high stood at $62.3 million for Q3 2021, and its period low was -$39.6 million during Q1 2022.
  • Its 3-year average for Change in Accured Expenses is $2.2 million, with a median of $6.7 million in 2024.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 2,742.90% in 2021, then tumbled by 1,290.55% in 2022.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Change in Accured Expenses stood at -$30.4 million in 2021, then skyrocketed by 81.08% to -$5.7 million in 2022, then skyrocketed by 247.15% to $8.5 million in 2023, then declined by 16.43% to $7.1 million in 2024, then slumped by 377.80% to -$10.0 million in 2025.
  • Its last three reported values are -$10.0 million in Q3 2025, $10.8 million for Q2 2025, and -$7.4 million during Q1 2025.